Bixiye
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Natiijooyinka Raadinta
Soo bandhiga 1011 - 1020 ee natiijooyinka 4297
Bixiye
P36-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P37-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective July 31, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
QP106-23 Update for New to Market Medical Drugs: Casgevy and Lyfgenia
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP107-23 Provider Press: Q4 2023
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP108-23 Commercial Pharmacy Benefit Exclusion for Adzynma
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP109-23 MHCP Pharmacy Benefit Exclusion for Adzynma and Loqtorzi™
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP99-23 Update for New to Market Medical Drugs: Zymfentra
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2023
Bixiye
QP100-23 Commercial Pharmacy Benefit Exclusion for Cosentyx® and Omvoh™
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2023
Bixiye
QP101-23 MHCP Pharmacy Benefit Exclusion for Cosentyx®, Omvoh™, and Tofidence™
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2023